The field of urologic oncology is experiencing rapid progress in recent years, fueled by innovations in diagnosis, treatment, and patient care. Innovative therapeutic modalities such as targeted therapy and immunotherapy are revolutionizing the landscape of urologic cancer management. Additionally, advancements in imaging techniques enable earlier